Medico-social Description of Seniors Living With HIV, Associated With a Qualitative Survey on Their Care in the Paris Region Structures
VIAGE
1 other identifier
observational
260
1 country
1
Brief Summary
This study is part of a national vision to fight against serophobia and support society towards more ethical and benevolent practices vis-à-vis aging and specific populations. The main objective of this study is to assess over the past five years the prevalence of people living with the Human Immunodeficiency Virus (HIV) aged 60 years and over and its evolution within the Paris Region medico-social structures
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 22, 2021
CompletedFirst Submitted
Initial submission to the registry
November 15, 2021
CompletedFirst Posted
Study publicly available on registry
November 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2024
CompletedJanuary 12, 2023
January 1, 2023
2.1 years
November 15, 2021
January 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The number of past situations for the last 5 years before the implementation of the study - of elderly people living with HIV in Retirement Home (EHPAD), home nursing care departments (SSIAD) and extended care units (USLD) in Île-de-France.
2 years
The number of current situations for the last 5 years before the implementation of the study - of elderly people living with HIV in Retirement Home (EHPAD), home nursing care departments (SSIAD) and extended care units (USLD) in Île-de-France.
2 years
Secondary Outcomes (10)
Assessment of the degree of patient dependence according "Index of Independence in Activities of Daily Living" KATZ scale
2 years
Assessment of patient's level of dependence through an appreciation of instrumental activities of daily living according Lawton scale
2 years
Assessment of depression according MINI Geriatric depression scale (Mini-GDS)
2 years
Screening for undernutrition using Mini Nutritional Assessment (MNA)
2 years
Assessment of quality of life according WHOQOL-HIV-BREF SCORE
2 years
- +5 more secondary outcomes
Eligibility Criteria
HIV-positive patients in Paris region medico-social sector, their informal caregivers and health professionals in the medico-social sector.
You may qualify if:
- For patients:
- HIV-positive, regardless of strain or age of infection,
- Orally expressing his non-opposition to his participation in the study and documented in the medical file by investigator,
- Follow-up, placed and / or treated in one of the centers concerned by the scope of the study in Paris Region.
- Since informal caregivers can be included in the study by being linked to a previously included patient, the patient must agree to share the status with informal caregiver, or have previously shared their status with informal caregiver.
- Patients with legal protection may participate only if:
- They clearly agree that their legal representative should be consulted on participation in the study,
- They accept that this person is aware of their HIV status ,
- After having been consulted, this person (legally responsible) does not object to the participation of the person for whom he is responsible.
- For informal caregiver:
- Person having a caring activity, before and during the study (such as the spouse, a child, a parent, neighbor, support person, etc.), for his close patient participating in the study,
- Authorized by the patient to be offered the study; the patient's agreement to approach the informal caregiver will have been sought beforehand in order to prevent the lack of medical confidentiality,
- Person expressing orally his non-opposition to his participation in the study and documented in the medical file of the patient to whom he is helping,
- Person capable of understanding the questionnaires and assessments of the study and able to answer them without the assistance of a third party.
- For health professionals :
- +2 more criteria
You may not qualify if:
- For patients:
- Patient expressing his opposition to his participation in the study,
- Patient who - according to the investigator - is unable to understand the study or answer the study questionnaires,
- For informal caregivers:
- Person not having a helping activity or exercising his role of helping for remuneration, or exercising his role of helping a loved one not included in the study,
- Person who exercises his role of helping in the context of a voluntary or associative activity,
- Person expressing orally his opposition to his participation in the study and documented in the medical file of the patient to whom he is helping,
- Person unable to understand the questionnaires and evaluations of the study and who is not able to answer them without the help of a third party,
- Person having the status of legal representative of the patient as part of a legal protection measure (guardianship and others).
- For health professionals :
- Health professional working in the non-Francilians health or medico-social sector,
- Health professional opposing participation in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gérond'iflead
Study Sites (1)
Geriatric Department, Broca hospital
Paris, IIe-de-France, 75013, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Olivier Hanon, MD PhD
Geriatric Department, Broca hospital,
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 15, 2021
First Posted
November 26, 2021
Study Start
September 22, 2021
Primary Completion
November 1, 2023
Study Completion
October 1, 2024
Last Updated
January 12, 2023
Record last verified: 2023-01